Our CEO, Evan Unger is recognized by the journal "Radiology"
David Lim named as our Director of Finance
Marty Rosenberg joins our Scientific Advisory Board
MVT awarded Phase I SBIR grant from the NCI
Microvascular Therapeutics Finalizes Facility Certification for the Production of MVT-100.
Microvascular Therapeutics receives funds from Commercialization Readiness Program
Timothy Healey Joins the Board of Directors at Microvascular Therapeutics
Evan C. Unger Receives Radiology Editor's Recognition Award
ImaRx Investments Receives ISO-7 Certification for Its GMP Manufacturing Suite
Shiv Kapoor Joins the Board of Directors at Microvascular Therapeutics
Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute
Microvascular Therapeutics enters licensing agreement with UNC Chapel Hill and Columbia University
Microvascular Therapeutics receives NIH SBIR Phase I funds for its Alzheimer program
Microvascular Therapeutics receives NIH SBIR Phase I funds for its program to treat heart attack
Microvascular Therapeutics Licenses Patent from Triangle Biotechnology Inc.
MVT Receives $1.7M Grant from National Heart, Lung, and Blood Institute of Health
Patent: Phospholipid Composition and Microbubbles and Emulsions Formed Using Same